Study and Implement the Spirit of the Third Plenary Session of the 20th Central Committee of the Party: Outreach Lecture Series Enters the Chamber of Commerce


Release date:

2024-11-28

On August 22, Li Xiuwu, Director of the Municipal Science and Technology Bureau, and Li Yanfu, Deputy Director, visited the Liaoyuan Pharmaceutical and Health Industry Chamber of Commerce to deliver a keynote speech on studying and implementing the spirit of the Third Plenary Session of the 20th Central Committee of the Communist Party of China. Attending the event were representatives from member companies including Jilin Boda Weiye Pharmaceutical Co., Ltd., Jilin Boda Pharmaceutical Co., Ltd., Liaoyuan YinYing Pharmaceutical Co., Ltd., Jilin ASEAN Pharmaceutical Co., Ltd., Jialida (Liaoyuan) Gelatin Co., Ltd., Liaoyuan Hongyuan Pharmaceutical Co., Ltd., Liaoyuan Dikang Pharmaceutical Co., Ltd., Liaoyuan Baikang Pharmaceutical Co., Ltd., and Liaoyuan Health Checkup Center.

Studying and Implementing the Spirit of the Third Plenary Session of the 20th Central Committee of the Party

宣讲课堂走进商会

August 22, Director Li Xiuwu of the Municipal Science and Technology Bureau, Deputy Director Li Yanfu Delivered a keynote speech at the Liaoyuan City Pharmaceutical and Health Industry Chamber of Commerce on studying and implementing the spirit of the Third Plenary Session of the 20th Central Committee of the Communist Party of China. Attendees from member organizations included Jilin Bodaweiyie Pharmaceutical Co., Ltd., Jilin Bodapharmaceutical Co., Ltd., Liaoyuan YinYing Pharmaceutical Co., Ltd., Jilin ASEAN Pharmaceutical Co., Ltd., Jialida (Liaoyuan) Gelatin Co., Ltd., Liaoyuan Hongyuan Pharmaceutical Co., Ltd., Liaoyuan Dikang Pharmaceutical Co., Ltd., Liaoyuan Baikang Pharmaceutical Co., Ltd., and Liaoyuan Health Checkup Center.

The meeting emphasized the need to earnestly implement the arrangements and requirements of the Third Plenary Session of the 20th Central Committee of the Party, and to firmly uphold innovation as the primary driving force behind development. It was stressed that we should leverage enhanced science and technology services as a key lever, focusing on "small yet impactful" areas for enterprise transformation and upgrading, identifying genuine technological needs, and achieving real breakthroughs in tackling critical technical challenges. Furthermore, we must continue deepening reforms, improving the quality and efficiency of our science and technology supply system, fostering the development of new, high-quality productive forces, and harnessing scientific and technological innovation to catalyze fresh momentum for growth.

 

Keywords: